{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:25:38Z","timestamp":1783387538053,"version":"3.54.6"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psychosis, including delusions and hallucinations, is a significant neuropsychiatric symptom in Alzheimer\u2019s disease (AD) associated with poor prognosis. The relationship between psychosis and AD pathology remains controversial. This study investigates the role of AD pathology in mediating the association between psychosis and cognitive impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Data were obtained from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). We included individuals with a Clinical Dementia Rating (CDR) score of 0.5 or higher. Among a total of 833 individuals, 96 individuals with psychosis were matched to 192 individuals without psychosis using propensity scores based on age, sex, education level, and follow-up duration. Baseline cognitive performance was assessed using composite memory scores (ADNI-MEM) and executive function scores (ADNI-EF). AD pathology was measured using baseline cerebralspinal fluid (CSF) levels of\n                      <jats:italic>\u03b2<\/jats:italic>\n                      -amyloid\n                      <jats:sub>1-42<\/jats:sub>\n                      (A\u03b2\n                      <jats:sub>1-42<\/jats:sub>\n                      ), hyperphosphorylated-tau\n                      <jats:sub>181<\/jats:sub>\n                      (p-tau\n                      <jats:sub>181<\/jats:sub>\n                      ), and total tau. Logistic regression was performed to evaluate the association of psychosis with baseline cognitive performance and CSF biomarkers. Mediation analysis was conducted to assess whether AD biomarkers mediate the relationship between cognitive impairment and psychosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Psychosis was significantly associated with worse ADNI MEM score (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.622,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.013) and worse ADNI EF score (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.516,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.003), and lower CSF A\u03b2\n                      <jats:sub>1-42<\/jats:sub>\n                      levels (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.009,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.007). No significant associations were found with p-tau\n                      <jats:sub>181<\/jats:sub>\n                      or total tau levels. Mediation analysis revealed that low CSF A\u03b2\n                      <jats:sub>1-42<\/jats:sub>\n                      levels mediated the relationship between cognitive impairment and psychosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that amyloid pathology may mediate the effect of baseline cognitive impairment on psychosis during disease in AD, highlighting a potential pathological link between cognitive decline and psychotic symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2025.1663120","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:12:34Z","timestamp":1768205554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of psychosis with cognitive impairment is mediated by amyloidopathy in cognitive impairment"],"prefix":"10.3389","volume":"17","author":[{"given":"Jung-Min","family":"Pyun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungjoo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Young","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Yun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Chul","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Won","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"and the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jalz.2015.05.005","article-title":"Alzheimer's disease neuroimaging initiative 2 clinical core: progress and plans","volume":"11","author":"Aisen","year":"2015","journal-title":"Alzheimers Dement."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11910-020-01074-y","article-title":"Psychosis in Alzheimer's disease","volume":"20","author":"Ballard","year":"2020","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fneur.2012.00073","article-title":"Behavioral and psychological symptoms of dementia","volume":"3","author":"Cerejeira","year":"2012","journal-title":"Front. Neurol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jagp.2017.10.011","article-title":"Psychosis and clinical outcomes in Alzheimer disease: a longitudinal study","volume":"26","author":"Connors","year":"2018","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","article-title":"Development and assessment of a composite score for memory in the Alzheimer's disease neuroimaging initiative (ADNI)","volume":"6","author":"Crane","year":"2012","journal-title":"Brain Imaging Behav."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/wnl.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1276","DOI":"10.1212\/WNL.0000000000012598","article-title":"Neuropsychiatric and cognitive symptoms across the Alzheimer disease clinical Spectrum: cross-sectional and longitudinal associations","volume":"97","author":"Eikelboom","year":"2021","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1001\/archpsyc.57.12.1165","article-title":"Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis","volume":"57","author":"Farber","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1159\/000339954","article-title":"Delusions increase functional impairment in Alzheimer's disease","volume":"33","author":"Fischer","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1192\/bjp.165.1.53","article-title":"Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease","volume":"165","author":"F\u00f6rstl","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11682-012-9176-1","article-title":"A composite score for executive functioning, validated in Alzheimer's disease neuroimaging initiative (ADNI) participants with baseline mild cognitive impairment","volume":"6","author":"Gibbons","year":"2012","journal-title":"Brain Imaging Behav."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1001\/jamapsychiatry.2024.1389","article-title":"Psychosis in Alzheimer disease and elevations in disease-relevant biomarkers","volume":"81","author":"Gomar","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41398-022-01850-z","article-title":"Increased retention of tau PET ligand [18F]-AV1451 in Alzheimer's disease psychosis","volume":"12","author":"Gomar","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e031947","DOI":"10.1136\/bmjopen-2019-031947","article-title":"Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study","volume":"9","author":"Goukasian","year":"2019","journal-title":"BMJ Open"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3233\/JAD-230918","article-title":"Amyloid pathology modulates the associations of neuropsychiatric symptoms with cognitive impairments and neurodegeneration in non-demented elderly","volume":"97","author":"Guo","year":"2024","journal-title":"J. of Alzheimers Dis."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/WAD.0000000000000250","article-title":"Psychosis in \"cognitively asymptomatic\" elderly subjects is associated with Neuritic plaque load, not neurofibrillary tangles","volume":"32","author":"Kim","year":"2018","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.neurobiolaging.2014.03.003","article-title":"Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities","volume":"35","author":"Koppel","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1176\/appi.ajp.2013.13040466","article-title":"Elevated CSF tau is associated with psychosis in Alzheimer's disease","volume":"170","author":"Koppel","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/alz.12007","article-title":"Mild behavioral impairment is associated with \u03b2-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals","volume":"16","author":"Lussier","year":"2020","journal-title":"Alzheimers Dement."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/wnl.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3233\/JAD-131166","article-title":"Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosis","volume":"39","author":"Murray","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/j.neurobiolaging.2012.02.015","article-title":"\u0392-Amyloid 42\/40 ratio and kalirin expression in Alzheimer disease with psychosis","volume":"33","author":"Murray","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/brain\/awaa413","article-title":"Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms","volume":"144","author":"Naasan","year":"2021","journal-title":"Brain"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1212\/wnl.54.10.1965","article-title":"Incidence of and risk factors for hallucinations and delusions in patients with probable AD","volume":"54","author":"Paulsen","year":"2000","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1176\/appi.ajp.2014.14040480","article-title":"Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County dementia progression study","volume":"172","author":"Peters","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1176\/appi.ajp.162.11.2022","article-title":"Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003","volume":"162","author":"Ropacki","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","article-title":"Constructing a control group using multivariate matched sampling methods that incorporate the propensity score","volume":"39","author":"Rosenbaum","year":"1985","journal-title":"Am. Stat."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1017\/S104161022200ssw1132","article-title":"Characteristics of very late-onset schizophrenia-like psychosis classified with the biomarkers for Alzheimer's disease: a retrospective cross-sectional study","volume":"36","author":"Satake","year":"2024","journal-title":"Int. Psychogeriatr."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1001\/archneur.62.10.1601","article-title":"Delusions and hallucinations are associated with worse outcome in Alzheimer disease","volume":"62","author":"Scarmeas","year":"2005","journal-title":"Arch. Neurol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/gps.1858","article-title":"Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County study","volume":"23","author":"Steinberg","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1017\/S1041610216001654","article-title":"Causes of nursing home placement for older people with dementia: a systematic review and meta-analysis","volume":"29","author":"Toot","year":"2017","journal-title":"Int. Psychogeriatr."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e1564","DOI":"10.4088\/JCP.15m10617","article-title":"Incident psychosis in subjects with mild cognitive impairment or Alzheimer's disease","volume":"77","author":"Weamer","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1017\/S1041610208007734","article-title":"The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis","volume":"21","author":"Weamer","year":"2009","journal-title":"Int. Psychogeriatr."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/archneur.1991.00530180075020","article-title":"Neuropathologic and neurochemical correlates of psychosis in primary dementia","volume":"48","author":"Zubenko","year":"1991","journal-title":"Arch. Neurol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1663120\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:12:35Z","timestamp":1768205555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1663120\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":36,"alternative-id":["10.3389\/fnagi.2025.1663120"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2025.1663120","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1663120"}}